Brain metastasis drug study shows promise for lung cancer patients
NCT ID NCT07239102
Summary
This study looked back at the medical records of 300 lung cancer patients whose cancer had spread to the brain or spinal cord. All patients had a specific genetic change (EGFR+) and were treated with the drug firmonertinib. Researchers analyzed how well the drug controlled the cancer in the brain and how long patients lived without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Li Xiaoyan
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.